Clinical Trial Update: Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study evaluating a triplet chemotherapy regimen—liposomal irinotecan combined with temozolomide and vincristine—for pediatric pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Liposomal irinotecan (liposomal irinotecan)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Yizhuo Zhang | Conditions: Solid Tumor Cancer | Phase 1 | Status: NOT_YET_RECRUITING